Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial
暂无分享,去创建一个
[1] T. Jacobson. The Lower the Better in Hypercholesterolemia Therapy: A Reliable Clinical Guideline? , 2000, Annals of Internal Medicine.
[2] W. Brown. Cholesterol lowering in atherosclerosis. , 2000, The American journal of cardiology.
[3] Wollersheim,et al. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia , 2000, European journal of clinical investigation.
[4] G. Mancini,et al. Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. , 1999, Clinical and investigative medicine. Medecine clinique et experimentale.
[5] O. Faergeman,et al. Effect of greater LDL-C reductions on prognosis-the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial , 1999 .
[6] Tonstad,et al. Carotid intima–media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects , 1998, European journal of clinical investigation.
[7] G. Boers,et al. Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[8] G. Mancia,et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.
[9] G. Thorgeirsson,et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) , 1998, Circulation.
[10] R H Selzer,et al. The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.
[11] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[12] N. Nishi,et al. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. , 1997, Stroke.
[13] Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. , 1997, The New England journal of medicine.
[14] A. Stalenhoef,et al. Effect of Apheresis of Low-Density Lipoprotein on Peripheral Vascular Disease in Hypercholesterolemic Patients with Coronary Artery Disease , 1996, Annals of Internal Medicine.
[15] S. Azen,et al. Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy , 1996, Annals of Internal Medicine.
[16] G. Schectman,et al. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals. , 1996, The American journal of medicine.
[17] J. Salonen,et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. , 1995, Circulation.
[18] D. Sprecher,et al. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[19] P M Rautaharju,et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. , 1995, Stroke.
[20] F. Leus,et al. Influence of apolipoprotein(a) phenotype on lipoprotein(a) quantification: evaluation of three methods. , 1994, Clinical biochemistry.
[21] C. Furberg,et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.
[22] P. Touboul,et al. Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[23] M L Bots,et al. Cardiovascular Determinants of Carotid Artery Disease: The Rotterdam Elderly Study , 1992, Hypertension.
[24] Bob Margulies,et al. Task force report , 1991 .
[25] J. Hendriks,et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[26] M J Malloy,et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. , 1990, JAMA.
[27] M. Lopes-Virella,et al. Immunonephelometric assay of human apolipoprotein AI. , 1980, Clinical Chemistry.
[28] M. Trip,et al. Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia , 2000, Clinical drug investigation.
[29] A. Folsom,et al. Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study. , 1996, Ultrasound in medicine & biology.